Clinical Trial Update: The Effects of Glucose/Ischemic Preconditioning on Reperfusion Injury in Deceased-Donor Liver Transplantation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating glucose/ischemic preconditioning to reduce reperfusion injury in deceased-donor liver transplantation; the study was terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation

Drugs mentioned

• Glucose/Ischemic Preconditioning

Snippet

Sponsor: University Health Network, Toronto | Conditions: Liver Transplantation | Phase 3 | Status: TERMINATED